Journal
TRENDS IN IMMUNOLOGY
Volume 31, Issue 1, Pages 39-44Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.it.2009.10.001
Keywords
-
Categories
Funding
- NIH [AI51626, AI065566, AI073955]
- Penn State College of Agricultural Sciences
- NASA
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI073955, R01AI073955, R01AI065566, R01AI051626, R56AI065566] Funding Source: NIH RePORTER
Ask authors/readers for more resources
The eosinophil has been perceived as a terminal effector cell in allergic airway diseases. However, recent work has shown that this multifunctional cell could be more involved in the initial stages of allergic disease development than was previously thought, particularly with regard to the ability of the eosinophil to modulate T-cell responses. In this review, we discuss recent advances that suggest that eosinophils can present antigen to naive as well as to antigen-experienced T cells, induce T helper 2 cell development, cytokine production or both, and affect T-cell migration to sites of inflammation. These findings are changing the way that eosinophil function in disease is perceived, and represent a shift in the dogma of allergic disease development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available